ARTL · Artelo Biosciences, Inc.
Market Cap
$3.25M
Shares
510,563
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$12.88M
-31.1%
FY2025
Diluted EPS
-$338.04
+31.6%
FY2025
Operating Cash Flow
-$8.52M
-2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $3.82M | $5.42M | $5.99M | $5.7M | $4.32M | $3.78M | $1.92M | $1.09M | $1.25M | — | — | — | |
| $7.25M | $5.98M | $4.12M | $4.23M | $5.96M | $5.63M | $1.79M | $952.33K | $508.28K | $107.53K | $752 | $509 | |
| $11.07M | $11.4M | $10.11M | $9.93M | $10.29M | $9.42M | $4.69M | $3.21M | $2.34M | $232.79K | $29.69K | $15.24K | |
| -$11.07M | -$11.4M | -$10.11M | -$9.93M | -$10.29M | -$9.42M | -$4.69M | -$3.21M | -$2.34M | -$232.79K | -$29.69K | -$15.24K | |
| $228K | $194K | $0 | $0 | $5000 | — | — | — | $2100 | $2100 | — | — | |
| -$1.6M | -$1.48M | $282K | $641K | $204K | $10K | $30.91K | $1.04M | -$2100 | -$2100 | — | — | |
| — | $22K | $0 | — | — | — | — | — | — | — | — | — | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | |
| -$12.67M | -$12.88M | -$9.83M | -$9.29M | -$10.08M | -$9.41M | -$4.65M | -$2.17M | -$2.34M | -$234.89K | -$29.69K | -$15.24K | |
| -$12.62M | -$12.95M | -$9.83M | -$9.24M | -$10.32M | -$9.47M | -$4.58M | -$2.17M | -$2.36M | -$234.23K | — | — | |
| USD/shares | -$3,037.50 | — | — | — | — | — | — | -$2,430.00 | — | — | — | — |
| USD/shares | -$119.07 | -$338.04 | -$494.10 | -$508.68 | — | — | — | -$3,547.80 | — | — | — | — |
| shares | — | — | — | — | — | 7.69M | 1525.7819 | 894.0185 | 4205.851 | 3593.5827 | 3144.0329 | 2636.3942 |
| shares | — | 38.11K | 19.89K | 18.27K | — | 7.69M | 1525.7819 | 894.0185 | 1795.1823 | 3593.5827 | 3144.0329 | 2636.3942 |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 2.02×
EV/EBIT
—
P/E (TTM)
—
Peer medians compare against the 131 similar-size Biotechnology companies (of 514 listed).
Key facts
CIK
1621221
CUSIP
04301G706
13F (30d)
11 filings
11 filers
Visit website
Investor relations